Immunomodulator FTY720 Induces Myofibroblast Differentiation via the Lysophospholipid Receptor S1P3 and Smad3 Signaling
Christina Keller(Freie Universität Berlin), Burkhard Kleuser(Freie Universität Berlin), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Markus van der Giet(Charité - Universitätsmedizin Berlin), Markus Tölle(Charité - Universitätsmedizin Berlin), Heinfried H. Radeke(Goethe University Frankfurt), Monika Schäfer‐Korting(Freie Universität Berlin), Pilar Rivera Gil(Freie Universität Berlin)
Cited by 89
Related Papers
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
|Clinical Neuropharmacology|2010|794